Coronary Artery Bypass Surgery in Patients Over Age 70 Years: Report from the Milwaukee Cardiovascular Data Registry

Size: px
Start display at page:

Download "Coronary Artery Bypass Surgery in Patients Over Age 70 Years: Report from the Milwaukee Cardiovascular Data Registry"

Transcription

1 Clin. Cardiol. 10, (1987) Original Contributions Coronary Artery Bypass Surgery in Patients Over Age 70 Years: Report from the Milwaukee Cardiovascular Data Registry G. DORROS, M.D., R. F. LEWIN, M.D.,*P. DALEY, M.D.,J. ASSA, M.S. Medical College of Wisconsin and * St. Luke s Hospital, Milwaukee, Wisconsin, USA Summary: Between 1972 and 1985,674 coronary bypass patients 2 70 years (70% male, mean age 73 years) were among 10,622 patients with both catheterization and operative data entered into the Milwaukee Cardiovascular Data Registry. These 2 70 years patients were analyzed regarding the operative morbidity, the 30day operative mortality, and the operative mortality s relation to coronary artery disease and ventricular wall motion abnormalities. The operative mortality was not different for the 174 patients operated upon before and the 500 patients after A mean of 3.4 grafts were placed during surgery. The complications encountered included a 7.1 % perioperative infarction rate, a 4.2% incidence of cerebrovascular accident, a 3.6% incidence of reoperation for bleeding, a 2.4% incidence of renal failure, and a 2.1 % incidence of pulmonary embolism. The overall operative mortality was 7.4%. The extent of coronary artery disease was distributed among patients such that 8.4% had single, 28.0% had double, and 63.6 % had triplevessel disease. The operative mortality as related to the extent of coronary artery disease was 5.2% for single, 8.9% for double, and 7.0% for triplevessel disease. The operative mortality was 6.7% with no and 7.9% with left ventricular wall motion abnormalities. The operative mortality was 1.9% with 1 segmental wall motion abnormality, and increased to 13.3% (~~0.05) with 46 segmental wall motion abnormalities. The operative mortality for singlevessel disease was 5.4% with normal and 4.3% with abnormal wall motion; for Address for reprints: Gerald Donos, M.D. Associate Professor of Medicine St. Luke s Health Sciences Building 2901 W. Kinnickinnic River Parkway Suite 512 Milwaukee, WI 53215, USA Received: Febmary 23, 1987 Accepted: April doublevessel disease it was 4.3 % with normal and 13.2 % with abnormal wall motion, (~~0.05); and, for triplevessel disease, 8.3% with normal and 6.0% with abnormal wall motion. Actuarial lifetable analysis indicated that the probability of surviving at least 7 years is 64.6 f 3.6 I. There was no difference in the survival at 4 years regardless of the extent of coronary disease. After 4 years, the difference in survival between single and triplevessel disease became significant (single, 91 % versus triple, 78%; p<0.05). The probability of survival at 7 years was affected by the presence of wall motion abnormalities (normal, 73% versus abnormal, 5696, ~ ~0.05). These data suggest that coronary bypass surgery when performed in patients 2 70 years has a significant operative mortality which is probably not related to the extent of coronary artery disease, but to the severity of left ventricular wall motion abnormalities. Surviving patients have a relatively good longterm outlook which, nevettheless, is adversely affected by the extent of coronary disease, and the severity of left ventricular wall motion abnormalities. Key words: bypass surgery, geriatric population, longterm followup, lifetable analysis Introduction Patients greater than age 70 years constitute a growing segment of our population whose relatively good health may be m d by symptomatic coronary disease. Comnary artery bypass graft surgery has been utilized reluctantly to treat selected members of this symptomatic geriatric population because of the associated significant surgical morbidity and This communication will report the Milwaukee Cardiovascular Data Registry s experience of patients over the age of 70 years who underwent their fht coronary bypass surgical pmedure with regard to the operative mortality and the 30day operative mortality s relationship to the extent of coronary artery disease, and to the severity of left ventricular wall motion abnormalities.

2 378 Clin. Cdiol. Vol. 10, July 1987 Methods The Milwaukee Cardiovascular Data Registry is a voluntary registry, composed of cardiovascular surgeons and cardiologists which has compiled data on patients who underwent cardiac surgery since Between 1972 and 1985,10,622 patients have been entered into the Milwaukee Cardiovascular Data Registry, with complete surgical and catheterization data, who underwent their first myocardial revascularization surgery without any concomitant surgical procedures (i.e., valve replacement, aneurysmectomy, Vineberg implant, or carotid endarterectomy). Followup data was obtained by yearly written questionnaires. There were 674 patients over age 70 years who were operated upon, and their catheterization and surgical data were analyzed with regard to the operative mohidity, and the 30day operative mortality and its relationship to the extent of coronary artery disease and presence or absence of left ventricular wall motion abnormalities. Analysis of the relationship of the extent of coronary disease and left ventricular wall motion abnormalities was done by grouping patients into single, double, and triplevessel disease, and relating the absence (normal) or presence (abnormal) of left ventricular wall motion abnormalities to each pup. The singlevessel group was too small to analyze since it consisted of 57 patients of whom 20 had left ventricular dysfunction. Patient followup utilizing the lifetable methodz1 was performed to show the effect of the extent of coronary disease and the presence of left ventricular wall motion abnormalities upon longterm survival. Complications, apart from mortality, were not included in the Data Registry forms. A review of the computerized patient records was performed in order to determine the incidence of complications as listed by the operator at hospital discharge. The complications listed included cerebrovascular accident, transient ischemic attack, postoperative myocardial infaxtion, postoperative renal failure, postoperative wound infection, pulmonary embolism, and mperation for bleeding. Data on myocardial revascularhation has been collected by the Milwaukee Cardiovascular Data Registry since However, during the early years of bypass surgery, few operations were performed upon patients over 70 years of age. Therefore, a retrospective data analysis was begun with cases performed between January 1972 and December Selective coronary arteriography and left ventricular angiography had been performed in each patient prior to surgery. Coronary attery disease was defined as a 2 50% diameter stenosis in a major epicardial coronary artery. As previously repo~ted, ~ data on ventricular wall motion obtained from the coronary angiogmn were recorded for each of six left ventricular segments utilizing the right anterior oblique view: high, mid and low segments in the inferior wall and high, mid and low segments in the anterior wall. The ventriculogram was divided into six segments. For each of the left ventricular segments, the wall motion was classified as normal, hypokinetic, akinetic, or dyskinetic. All data is presented as mean value f standard deviation, apart from lifetable analysis where the standard error is utilized. Comparison between groups was done utilizing Chisquare analysis for discrete variables. Results Between 1972 and 1985, there were 674 patients over the age of 70 years who underwent their first bypass surgery (Table I). Because of changes in surgical techniques, patient selection, and the concept of a surgical learning curve, a comparative study was performed to determine if there was a difference in the 30day operative mortality between the early ( , 174 patients) and late ( ,500 patients) experience of the registry. No statistically significant difference was found between these two groups regarding their age, sex, extent of coronary disease, left ventricular dysfunction, or operative mortality. Further analyses were performed on the group as a single entity, and all data presented represented the entire group. Despite the fact that doublevessel and triplevessel coronary disease accounted for 91.6% of the patient population, the operative mortality (Table II) did not differ significantly between single, double, or triplevessel disease. Even utilization of an occlusion score systemz3 which weighted the individual coronary vessels as to their vary TABLE I Clinical characteristics of patients greater than 70 Y Patients Male Female Mean age (yrs) Mean graftstpatient One graft Two grafts Three grafts Four grafts Five grafts Six or more grafts Distribution of coronary disease Singlevessel disease Doublevessel disease Triplevessel disease Left ventricular function Normal (i.e., no abnormalities) 13 Abnormal segments 4 Abnormal segments 5 Abnormal segments 6 Abnormal segments (70%) 203 (30%) 73 f (4.7%) 118 (17.5%) 224 (33.2%) 174 (25.9%) 96 (14.3%) 30 (4.4%) 57 (8.5%) 189 (28.0%) %) 309 (45.8%) 278 (41.2%) 36 (5.3%) 24 (3.6%) 27 (4.1%)

3 TABLE I1 Relationship of the extent of coronary disease and left ventricular wall motion abnormalities to the 30day operative mortality G. Dorms et al.: Bypass surgery in patients L 70 years 379 Mortality related to extent of coronary disease Overall 50 (7.4%) Singlevessel disease 3 (5.2%) Doublevessel disease 17 (8.9%) Triplevessel disease 30 (7.0%) Mortality related to ventricular wall motion abnormalities Normal left ventricular wall motion 21 (6.7%) Abnormal left ventricular wall motion 29 (7.9%) 1 Abnormal segment 2 (1.9%) 23 Abnormal segments 15 (8.9%) 46 Abnormal segments 12( 13.3 %) Mortality related to extent of coronary artery disease and left ventricular wall motion abnormalities Singlevessel disease Normal 2 (5.4%) Abnormal 1 (4.9%) Doublevessel disease Normal 4 (4.3%) Abnormal 13(13.2%) Triplevessel disease Normal 15 (8.3%) Abnormal 15 (6.0%).18 FIG. 1 Lifetable analysis of bypass surgery patients over age 70 years. The parentheses ( ) express the population at risk at the end of each year. n=674. ing importance likewise showed no effect upon the 30 day operative mortality. The 7.4% mortality for patients over 70 years was significantly increased (p<0.05) above the Data Registry's mortality of 2.0% for all patients 5 70 years (a 1.6% mortality with normal left ventricular wall motion versus a 2.4% mortality with multiple left ventricular wall motion abnormalities, p <0.05). This must be contrasted to the geriatric patients in whom the mortality with normal left ventricular wall motion was 6.7% (Table 11), and significantly increased to 13.3% (p ~0.05) with multiple left ventricular wall motion abnormalities. In the presence of doublevessel disease, the mortality significantly increased (~0.05) from 4.3% with normal (none) to 13.2% with abnormal (multiple) left ventricular wall motion abnormalities. The mortality for triplevessel disease was high, and significantly (p < 0.05) increased only in the late group with 46 abnormal ventricular wall motion segments (mortality, 18%). Followup data was analyzed using the lifetable method. Despite the relatively high surgical mortality, the surviving patients had (Fig. 1) a 61 % probability of being alive at 8 years. There was no statistically significant difference in the cumulative survival at 3 years regardless of the extent of coronary disease (Fig. 2). However, at 4 years, the difference in survival between singlevessel and triplevessel disease became statistically significant (single vessel, 91 % versus triple vessel, 78%; pc0.05). The cumulative survival (Fig. 3) at 7% years did depend o1 i 5 B d h ci t I Years FIG. 2 Lifetable analysis of bypass surgery patients over age 70 years and the relationship of survival and the extent of coronary artery disease. The population at risk at the end of each period for each group is shown. SVD () =singlevessel disease; DVD ( ) =doublevessel disease; TVD ("") =triplevessel disease. upon left ventricular function (a 73 % survival with normal ventricular wall motion versus a 56% survival with abnormal ventricular wall motion, pc0.05). The complications encountered are listed in Table III. These complications were not mutually exclusive. Nine of the 24 patients who required a reoperation for bleeding had an additional complication including myocardial infarction (2 1 %), cerebrovascular accident (4 % ), renal failure (12%), pulmonary embolism (4%), and wound infection (4%).

4 380 Clin. Cadiol. Vol. 10, July 1987 ".. NLF250 NLF216 NLF161 NLF119 KLFW NLF54 NLF35 NLFaD ABNLF ABNLF ABNLF ABNLF WNLFABNLFABNLFABNLF W IS FIG. 3 Lifetable analysis of bypass surgery patients over age 70 years and the relationship of survival and left ventricular function (N. LF ()=normal left ventricular function; ABN. LF ( )= abnormal left ventricular function). The population at risk at the end of each period is shown at the bottom of the figure. Discussion Coronary artery bypass graft surgery has been utilized reluctantly to treat selected geriatric patients because of the reported associated significant surgical morbidity and mortality (Table IV). By and large, the published data concerning patients over 70 years of age who have undergone coronary artery bypass surgery is limited. The number of published reports with morbidity statistics are few. The mortality statistics have varied, with the mortality in some groups remaining relatively high while one report showed a decline in their high mortality statisticss which was attributed to the surgical learning experience. However, in our study, there was no difference in the lack of decrease in mortality between the early and late surgical experience. This lack of difference may actually represent improvements in surgical techniques and surgical experience which enabled more difficult surgical cases to be attempted which TABLE III Complications' encountered in coronary artery bypass surgery in patients over age 70 years Postoperative myocardial infarction 47 (7.1%) Cerebrovascular accident 28 (4.2%) Reoperation for bleeding 24 (3.6%) Postoperative renal failure 16 (2.4%) Pulmonary embolism 14 (2.1%) Postoperative wound infection 11 (1.7%) Transient ischemic attack 5 (0.8%) a Complications encountered were not mutually exclusive. had higher surgical risks. However, as in every retrospective study involving the use of dynamic variables (i.e., surgical techniques, patient selection, surgical experience), the data must always be viewed with this in mind. However, this problem should not prevent analysis of such retrospective data which still can provide us with important information. Reported morbidity associated with myocardial revascularization surgery is difficult to find. Fm ef al. repotted a 10.5% operative mortality in 105 patients over the age of 70 along with significant morbidity figures: cerebrovascular accidents in 8.6 %, mperation for bleeding in 8.5 %, red failm in 5.7 %I. Cardiac complications including myocardial infarction, congestive heart failure, and arrhythmias were present in 44.8% of cases. However, the vast majority of surgical reports fail to list comorbidity statistics. Therefore, the assessment of the incidence of possible postoperative complications in the geriatric patient [including neurologic deficits (tmnsient or permanent), perioperative infarctions, or other cardiovascular, pulmonary or renal problems] is difficult, if not impossible, to achieve. The fact that the morbidity in this patient group is not negligible is supported by our data. In addition, within our series, reoperation for surgical bleeding increased the likelihood of additional concomitant complications. The mortality of the geriatric population remains significant even if the mortality statistics are stratified for age. In the coronary artery surgical study,9 the mortality increased with increasing age: Age 6569, 4.6%; 7074, 6.6%; and, 1 75 years, 9.5%. The overall surgical mortality of 7.9% of the Milwaukee Cardiovascular Data Registry is in keeping with the previously published reports. However, analysis of this 30day operative mortality with regard to the extent of coronary disease and its relationship to left ventricular wall motion abnormalities is unique. Mortality was not adversely affected by the extent of coronary artery disease, but was related to the presence of significant left ventricular dysfunction. The cumulative probability of survival for the group was 61 % at 8 years after surgery. Survival was adversely affected by the extent of left ventricular wall motion abnormalities. In addition, longterm survival (more than 4 years) was adversely affected by the extent of coronary disease. Since the initial success (the first 4 years after surgery) showed no difference in survival, the subsequent significant difference in survival may be a reflection of the progression of coronary disease, and not an event related to surgery. It has been suggested in nonmndomized series of medical versus surgicaltreated groups2' that age is the only detrimental factor in their longterm prognosis. Our data suggest that geriatric patients (over age 70 years) who cannot be medically managed can undergo myocardial revascularization surgery with a reasonable although significant operative mortality, and that the expected longterm survival rates are good in the patients who survive surgery. The extent of coronary disease should be the indication for direct myocardial revascularization surgery,

5 G. Dorms et al.: Bypass surgery in patients 2 70 years 381 TABLE IV Coronary artery bypass surgery in the elderly patient: mortality and morbidity Patient Age Ref. >65 yrs 170 yrs Mortality CVA Periopeative MI Confusion 1 total: 10" " a Patients 170 yrs 6 Male Female (11) (283) (5.1%) 2 (9.1%) 6 (6.0%) 1 (5.9%) 4 (10%) 3 (6.3%) 9 (4.3%) 8 (2.8%) 21 (22.1%) 0 (0%) 10 (15.6%) 4 (8.0%) 1 (2.9%) 1 (2.9%) 10 (11.8%) 1 (2.8%) 2 (3.1%) 2 (1.7%) 57 (2.7%) 20 (7.1%) 11 (10.5%) 5 (6.0%) 6 (28.6%) 74 (5.8%) 22 (13.9%) 52 (4.7%) 2 (2.0%) 2 (4.2%) 16 (6.0%) 1 (2.0%) 2 (2.4%) 4 (11.4%) 2 (3.1%) 3 (2.5%) 9 (8.6%) 2 (2.0%) 1 (5.9%) 2 (4.2%) 15 (5.7%) 6 (6.3%) 1 (1.5%) 5 (10.0%) 3 (8.6%) 10 (11.8%) 3 (8.6%) 3 (4.6%) 4 (3.3%) "Refs. 10 and 21 may include repetitious data. Abbreviations: CVA =cerebrovascular accident (tmnsient or permanent neurologic deficit); MI =myocardial infarction. whereas ventricular function as determined by wall motion abnormalities must be clearly defined, so as to permit an accurate assessment of the perioperative risk. Clearly, elderly patients sufficiently symptomatic to warrant myocardial revascularization surgery for the first time did so because symptomatic coronary disease impaired their functional capacity, and not because of an expectation of increased longevity. Surprisingly, the 8year probability of survival of the entire group was 61 %, which means that nearly two thirds of these symptomatic geriatric patients might be expected to live to age 81. Perhaps, myocardial revascularization surgery may have contributed to this unexpected increase in longevity. These findings require corroboration by further studies. References 1. Ashor GW, Meyer BW, Lindesmith GG, Stiles QR, Walker GH, Tucker BL: Coronary artery disease: Surgery in 100 patients 65 years of age and older. Arch Surg 107, 30 (1973) 2. Barnhorst DA, Guilian ER, Pluth JR, Danielson GK, Wallace RB, McGoon DC: Openheart surgery in patients more than 65 years old. Ann 7korac Surg 18, 81 (1974) 3. Berry BE, Acree PW, Davis DT, Sheely CH, Cavin S: Coronary artery bypass operations in septuagenerians. Ann Thorac Surg 31, 310 (1981) 4. DuCailar C, Chaitman BR, CastonGuay Y: Risks and benefits of aortocoronary bypass surgery in patients aged 65 years or more. Can Med Assoc J 122, 771 (1980) 5. Elayda MA, Hall RJ, Gray AG, Mathur VS, Cooley DA: Coronary revascularization in the elderly patient. J Am Coll Cardi 01 3, 1398 (1984) 6. Faro RS, Golden MD, Javid H, Seny C, DeLaria G, Monson D, Weinberg M, Hunter JA, Najafi H: Coronary revascularization in septuagenarians. J lhorac Cardiovasc Surg 86, 616 (1983) 7. Gann D, Colin C, Hildner FJ, Samet P, Yarh WZ, Greenberg JJ: Coronary artery bypass surgery in patients seventy years of age and older. J lhorac Cardiovusc Surg 73, 237 (1977) 8. Garcia JM, Cheanvechai C, Effler DB: Myocardial revascularization in patients aged 65 and older. Cardiovasc Clin 7, 83 (1975) 9. Gersh BJ, Kronmal RA, Frye RL: Coronary arteriography and coronary artery bypass surgery: Morbidity and mortality in patients aged 65 years or older. Circulation 67, 483 (1983)

6 3 82 Clin. Cardiol. Vol. 10, July Hamby RI, Wisoff G, Kolker P, Harstein M: Intractable angi M pectoris in the 65 to 79 year age pup: A surgical approach. Chest 64, 46 (1973) 11. Higginbotham M, Hunt D, White A, Clarebrough J: Surgical treatment of angina pectoris in the elderly. Med J Aust 2, 664 (1981) 12. Knapp WS, Douglas JS Jr, Craver JM, Jones EL, King III SB, Bone DK, Bradford JM, Hatcher CR: Efficacy of coronary artery bypass grafting in elderly patients with coronary rutery disease. Am J Cardiol47, 923 (1981) 13. Kuan P, Bemstein SB, Ellestad MH: Coronary artery bypass surgery morbidity. J Am Coll Cardiol 3, 1391 (1984) 14. LaFollette L, Jacobson LB, Hill JD: Isolated aortocoronary bypass operations in patients over 70 years of age. West J Med 133, 15 (1980) 15. McCallister BD, Schmeidt M, Reed WA, Killen DA, Crockett JE, Mc Conahay DR, Bell HH: Coronary artery bypass in patients over the age of 70: Initial and late results (abstr). Circulation 51 (suppl II), 1191 (1975) 16. MeyerJ, Wukasch DC, SeyboldEpting W, Chiarello L, Reul GJ, Sandiforo FM, Hallman GL, Cooley DA: Coronary artery bypass in patients over 70 years of age: Indications and results. Am J Cardiol 36, 342 (1975) 17. Smith JM, Lindsay WG, Lillehei RC, Nicoloff DM: Cardiac surgery in geriatric patients. Surgery 80, 443 (1976) 18. Stephenson LW, MacVaugh H JII, Edmonds LH: Surgery using cardiopulmonary bypass in the elderly. Circulation 58, 250 (1978) 19. Stringer RJ, Tucker BL, Stefanik G, Stiles QR, Lindesmith GG, Meyer BW: Coronary bypass grafting in the older age group. Circulation 51 (suppl II), (1975) 20. Tucker BL, Lindesmith GG, Stiles QR, Hughes RK, Meyer BN: Myocardial revascularization in patients 70 years of age and older. West J Med 1126, 179 (1977) 21. Wisoff GB, Harstein ML, Aintalian A, Hamby RI: Results of open heat surgery in the septuagenerian. J Geronrol3 1, 275 (1976) 22. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chon Dis 8, 699 (1958) 23. Hark AJ, Anderson AJ, Brooks HC, Manley JC, Parent GT, Barboriak JJ: The association of smoking with cardiomyopathy. N Engl J Med 34, 1201 (1984) 24. Vigilante GJ, Weintraub WS, Klein LW, Schneider RM, Seelaus PA, Pan GVS, Aganval JB, Helfant RH: Medical and surgical survival in coronary artery disease in the 1980 s. Am J Cardiol 18, 926 (1986)

Coronary Artery Bypass Surgery in the Septuagenarian

Coronary Artery Bypass Surgery in the Septuagenarian Coronary Artery Bypass Surgery in the Septuagenarian Jerry B. Gooch, M.D., H. Edward Garrett, M.D., J.T. Davis, Jr., M.D., and Robert L. Richardson, M.D. Analyzed during a 3 -year period wvere 86 patientsfrom

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

Results of Reoperation

Results of Reoperation Results of Reoperation for Recurrent Angina Pectoris William I. Norwood, M.D., Lawrence H. Cohn, M.D., and John J. Collins, Jr., M.D. ABSTRACT Although a coronary bypass operation improves the quality

More information

Coronary atherosclerotic heart disease remains the number

Coronary atherosclerotic heart disease remains the number Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship

More information

Comparison of Long-term Efficacy of Medical Treatment versus Percutaneous Transluminal Coronary Angioplasty (PTCA) in Single-vessel Disease

Comparison of Long-term Efficacy of Medical Treatment versus Percutaneous Transluminal Coronary Angioplasty (PTCA) in Single-vessel Disease Comparison of Long-term Efficacy of Medical Treatment versus Percutaneous Transluminal Coronary Angioplasty (PTCA) in Single-vessel Disease Shinichiro NISHIYAMA, M.D., Takashi IWASE, M.D., Sugao ISHIWATA,

More information

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA

More information

Chapter 9: Cardiovascular Disease in Patients With ESRD

Chapter 9: Cardiovascular Disease in Patients With ESRD Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in adult ESRD patients, with atherosclerotic heart disease and congestive heart failure being the most common conditions

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Chapter 4: Cardiovascular Disease in Patients with CKD

Chapter 4: Cardiovascular Disease in Patients with CKD Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%

More information

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery*

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery* Clin. Cardiol. 7, 179-183 (1984) @ Clinical Cardiology Publishing Co., Inc. Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous

More information

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. Factors Relating to Late Sudden Death in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D. ABSTRACT The preoperative

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of

More information

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 CLINICAL COMMUNIQUé 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 69 The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 69, was introduced into clinical

More information

Open-Heart Surgery in Patients More than 65 Years Old

Open-Heart Surgery in Patients More than 65 Years Old Open-Heart Surgery in Patients More than 65 Years Old Donald A. Barnhorst, M.D., Emilio R. Giuliani, M.D., James R. Pluth, M.D., Gordon K. Danielson, M.D., Robert B. Wallace, M.D., and Dwight C. McGoon,

More information

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis

Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis Aortocoronary Bypass in the Treatment of Left Main Coronary Artery Stenosis W. C. Alford, Jr., M.D., I. J. Shaker, M.D., C. S. Thomas, Jr., M.D., W. S. Stoney, M.D., G. R. Burrus, M.D., and H. L. Page,

More information

Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5)

Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5) European Heart Journal Supplements () 3 (Supplement Q), Q39 Q43 Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA

More information

and Paul C. Taylor, M.D. ORIGINAL ARTICLES

and Paul C. Taylor, M.D. ORIGINAL ARTICLES ORIGINAL ARTICLES Trends in Selection and Results of Coronary Artery Reoperations Floyd D. Loop, M.D., Bruce W. Lytle, M.D., Carl C. Gill, M.D., Leonard A. R. Golding, M.D., Delos M. Cosgrove, M.D., and

More information

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi Takamoto, MD, Noboru Motomura, MD, Minoru Ono,

More information

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural

More information

Ventricular Function and the Native Coronary Circulation Five Years after Myocardial Revascularhation

Ventricular Function and the Native Coronary Circulation Five Years after Myocardial Revascularhation Ventricular Function and the Native Coronary Circulation Five Years after Myocardial Revascularhation Denis H. Tyras, M.D., Naseer Ahmad, M.D., George C. Kaiser, M.D., Hendrick B. Barner, M.D., John E.

More information

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근 Case (2011, 5) 74-years old gentleman Exertional chest pain Warfarin with good INR control Ex-smoker, social(?)

More information

Review of 131 Consecutive Patients Gerald F. Geisler, M.D., Maurice Adam, M.D., Ben F. Mitchel, M.D., Cary J. Lambert, M.D., and J. Peter Thiele, M.D.

Review of 131 Consecutive Patients Gerald F. Geisler, M.D., Maurice Adam, M.D., Ben F. Mitchel, M.D., Cary J. Lambert, M.D., and J. Peter Thiele, M.D. Treatment of Severe Coronary Artery Disease with 5, 6, and 7 Saphenous Vein Bypasses: Review of 131 Consecutive Patients Gerald F. Geisler, M.D., Maurice Adam, M.D., Ben F. Mitchel, M.D., Cary J. Lambert,

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

Coronary Bypass for Relief of Persistent Pain Following Acute Myocardial Infarction

Coronary Bypass for Relief of Persistent Pain Following Acute Myocardial Infarction Coronary Bypass for Relief of Persistent Pain Following Acute Myocardial Infarction Ellis L. Jones, M.D., Thad F. Waites, M.D., Joe M. Craver, M.D., James M. Bradford, Ph.D., John S. Douglas, M.D., Spencer

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon

More information

ATRIAL SEPTAL DEFECTS

ATRIAL SEPTAL DEFECTS ORIGINAL STUDY Long-term follow-up of children after repair of atrial septal defects JAMES MANDELIK, MD; DOUGLAS S. MOODIE, MD; RICHARD STERBA, MD; DANIEL MURPHY, MD; ELIOT ROSENKRANZ, MD; SHARON MEDENDORP,

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography

Management during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper

More information

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization Gregory D. Trachiotis, MD, and Albert J. Pfister, MD Washington Heart, Section for Thoracic and Cardiovascular

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS

POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS CHARLES A. HERZOG, M.D., JENNIE Z. MA, PH.D., AND ALLAN J. COLLINS, M.D. ABSTRACT Background Cardiovascular

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J

Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the

More information

Coronary arteriographic study of mild angina

Coronary arteriographic study of mild angina British HeartJournal, I975, 37, 752-756. Coronary arteriographic study of mild angina W. Walsh, A. F. Rickards, R. Balcon From the National Heart Chest Hospitals, London Chest Hospital, London The results

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

CLINICAL COMMUNIQUE 16 YEAR RESULTS

CLINICAL COMMUNIQUE 16 YEAR RESULTS CLINICAL COMMUNIQUE 6 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900 Introduction The Carpentier-Edwards PERIMOUNT Mitral Pericardial Valve, Model 6900, was introduced

More information

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. Combined Valvular and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D. ABSTRACT Between July, 97, and March, 975,45 patients underwent combined valvular

More information

Multivessel Coronary Artery Disease : CABG. Zürich, F. Siclari MD

Multivessel Coronary Artery Disease : CABG. Zürich, F. Siclari MD Multivessel Coronary Artery Disease : CABG Zürich, 10.06.2015 F. Siclari MD Coronary Artery Ruptured Plaque Pathological process with definite subsequent vascular changes most of them irreversible CABG

More information

N with increased early mortality after coronary artery

N with increased early mortality after coronary artery Factors Influencing Long-Term (10-Year to 15=Year) Survival After a Successful Coronary Artery Bypass Operation W. Dudley Johnson, MD, Jerold B. Brenowitz, MD, and Kenneth L. Kayser, MS Milwaukee Heart

More information

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty Distal Coronary rtery Dissection Following Percutaneous Transluminal Coronary ngioplasty Douglas. Murphy, M.D., Joseph M. Craver, M.D., and Spencer. King 111, M.D. STRCT The most common cause of acute

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Lnformation Coverage Guidance

Lnformation Coverage Guidance Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It

More information

Modeling Stroke Risk After Coronary Artery Bypass and Combined Coronary Artery Bypass and Carotid Endarterectomy

Modeling Stroke Risk After Coronary Artery Bypass and Combined Coronary Artery Bypass and Carotid Endarterectomy Modeling Stroke Risk After Coronary Artery Bypass and Combined Coronary Artery Bypass and Carotid Endarterectomy John J. Ricotta, MD; Daniel J. Char, MD; Salvador A. Cuadra, MD; Thomas V. Bilfinger, MD,

More information

Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia

Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia Marshall University Marshall Digital Scholar Internal Medicine Faculty Research Spring 5-2004 Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia Ellen A. Thompson

More information

From Recovery to Transplant: One Patient's Journey

From Recovery to Transplant: One Patient's Journey From Recovery to Transplant: One Patient's Journey Tonya Elliott, RN, MSN Assist Device and Thoracic Transplant Coordinator Inova Transplant Center at Inova Fairfax Hospital Falls Church, VA Introduction

More information

Cardiac disease is well known to be the leading cause

Cardiac disease is well known to be the leading cause Coronary Artery Bypass Grafting in Who Require Long-Term Dialysis Leena Khaitan, MD, Francis P. Sutter, DO, and Scott M. Goldman, MD Main Line Cardiothoracic Surgeons, Lankenau Hospital, Jefferson Health

More information

Controversies in Cardiac Surgery

Controversies in Cardiac Surgery Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm

More information

Transcoronary Chemical Ablation of Atrioventricular Conduction

Transcoronary Chemical Ablation of Atrioventricular Conduction 757 Transcoronary Chemical Ablation of Atrioventricular Conduction Pedro Brugada, MD, Hans de Swart, MD, Joep Smeets, MD, and Hein J.J. Wellens, MD In seven patients with symptomatic atrial fibrillation

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience.

Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience. ISPUB.COM The Internet Journal of Thoracic and Cardiovascular Surgery Volume 17 Number 1 Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience. J C Eze Citation

More information

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization Richard D. Schultz, M.D., Antonio V. Sterpetti, M.D., and Richard J. Feldhaus, M.D. ABSTRACT A ten-year review

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty

Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty Original Article Preoperative Parameters Predicting the Postoperative Course of Endoventricular Circular Patch Plasty Keiichiro Kondo, MD, Yoshihide Sawada, MD, and Shinjiro Sasaki, MD, PhD It is necessary

More information

Left ventricle pseudoaneurysm as late postoperative complication of a large apical aneurysm

Left ventricle pseudoaneurysm as late postoperative complication of a large apical aneurysm CASE REPORT Left ventricle pseudoaneurysm as late postoperative complication of a large apical aneurysm Mariana M. Floria 1, 4, Carmen Elena Pleșoianu 2, 4, Michel Buche 3, Baudouin Marchandise 4, Erwin

More information

PCI for Renal Artery stenosis

PCI for Renal Artery stenosis PCI for Renal Artery stenosis Why should we treat Renal Artery Stenosis? Natural History of RAS RAS is progressive disease Study Follow-up (months) Pts Progression N (%) Total occlusion Wollenweber Meaney

More information

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroscore Marzia Leacche, MD, John G. Byrne, MD, Natalia S. Solenkova,

More information

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30:

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30: CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD Teo et al, Canadian Journal of Cardiology 2014;30: 1482-1491 Parallel Paper: Canadian Cardiovascular Society Guidelines for the Diagnosis

More information

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh

The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh The diagnostic role of stress echocardiography in women with coronary artery disease: evidence based review John R. McKeogh Key points 1) Coronary artery disease in women differs from men in several ways,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.

More information

Impact of donor-transmitted coronary atherosclerosis on quality of life (QOL) and quality-adjusted life years (QALY) after heart transplantation

Impact of donor-transmitted coronary atherosclerosis on quality of life (QOL) and quality-adjusted life years (QALY) after heart transplantation 58 O. Grauhan et al. Applied Cardiopulmonary Pathophysiology 14: 58-65, 2010 Impact of donor-transmitted coronary atherosclerosis on quality of life (QOL) and quality-adjusted life years (QALY) after heart

More information

12 th Annual West Virginia ACC Meeting April 8, 2017

12 th Annual West Virginia ACC Meeting April 8, 2017 12 th Annual West Virginia ACC Meeting April 8, 2017 Rameez Sayyed, M.D., FACC, FSCAI Associate professor of Medicine Program Director for interventional cardiology Marshall University Joan C. Edwards

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Coronary angiography in patients undergoing carotid artery stenting reveals

Coronary angiography in patients undergoing carotid artery stenting reveals Heart Online First, published on March 10, 2005 as 10.1136/hrt.2004.050906 1 Coronary angiography in patients undergoing carotid artery stenting reveals a high incidence of significant coronary artery

More information

Incidence of renal failure in postoperative period of cardiovascular surgeries in India

Incidence of renal failure in postoperative period of cardiovascular surgeries in India Original article: Incidence of renal failure in postoperative period of cardiovascular surgeries in India 1Dr.Abhijeet Nikam*, 2 Dr. Abhay Sadre 1Department of Medicine, P.Dr. D.Y.Patil Medical College

More information

Cardiovascular disease is the leading cause of mortality in Western countries.

Cardiovascular disease is the leading cause of mortality in Western countries. Surgery for Acquired Cardiovascular Disease Holmes et al The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation

More information

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty

A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD

More information

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients

Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Left Ventricular Wall Resection for Aneurysm and Akinesia due to Coronary Artery Disease: Fifty Consecutive Patients Armand A. Lefemine, M.D., Rajagopalan Govindarajan, M.D., K. Ramaswamy, M.D., Harrison

More information

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy? Interactive CardioVascular and Thoracic Surgery Advance Access published May 7, 2012 Interactive CardioVascular and Thoracic Surgery 0 (2012) 1 5 doi:10.1093/icvts/ivr141 BEST EVIDENCE TOPIC Is a minimally

More information

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,

More information

Reciprocal ST depression in acute myocardial infarction

Reciprocal ST depression in acute myocardial infarction Reciprocal ST depression in acute myocardial infarction Br Heart J 1985; 54: 479-83 OLUSOLA ODEMUYIWA, IAN PEART, CATHERINE ALBERS, ROGER HALL From the Royal Victoria Infirmary, Newcastle upon Tyne SUMMARY

More information

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6 n&list_uids=17433949 64-Multislice Detector Computed Tomography Coronary Angiography as Potential Alternative

More information

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine

PCI in Patients with Transplant Coronary Artery Disease. Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine PCI in Patients with Transplant Coronary Artery Disease Michael S. Lee, MD, FACC, FSCAI Assistant Professor UCLA School of Medicine Faculty Disclosure Honararia for Boston Scientific, BMS, Daiichi Sankyo,

More information

USRDS UNITED STATES RENAL DATA SYSTEM

USRDS UNITED STATES RENAL DATA SYSTEM USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart

More information

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction

Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,

More information

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium

Risk Stratification of ACS Patients. Frans Van de Werf, MD, PhD University of Leuven, Belgium Risk Stratification of ACS Patients Frans Van de Werf, MD, PhD University of Leuven, Belgium Which type of ACS patients are we talking about to day? 4/14/2011 STEMI and NSTEMI in the NRMI registry from

More information

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were

More information

MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR RESTORATION

MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR RESTORATION MEDICAL POLICY SUBJECT: SURGICAL VENTRICULAR PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes A/ Professor Darren Walters On behalf of the ANZ Source Investigators Director of Cardiology Brisbane, Australia ANZ

More information

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

Exercise treadmill testing is frequently used in clinical practice to

Exercise treadmill testing is frequently used in clinical practice to Preventive Cardiology FEATURE Case Report 55 Commentary 59 Exercise capacity on treadmill predicts future cardiac events Pamela N. Peterson, MD, MSPH 1-3 David J. Magid, MD, MPH 3 P. Michael Ho, MD, PhD

More information